Latest Coronavirus news
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
posted November 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
posted November 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated
posted November 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
posted November 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Postoperative Complications Elevated for Patients With Systemic Lupus Erythematosus 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity Monthly Specialist Briefings
Stay Connected
